Specialty Enzymes (MCP-2056) - Global Industry Analysts, Inc.

Research Abstract

This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following product segments - Specialty Medical Enzymes, Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use segments discussed are Pharmaceuticals & Diagnostics, and Research/Biotechnology. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets.The report profiles 44 companies including many key and niche players such as Advanced Enzymes Technologies Limited, Amano Enzyme Inc., Aureozyme Inc., Biocon Ltd., Biozyme Laboratories Limited, Danisco A/S, Genencor International, Inc., Kinetic Biosystems, Inc., Maxygen Inc, Codexis Inc., Novozymes A/S, Seravac Biotech (Pty) Ltd, Specialty Enzymes & Biochemicals Co., and Verenium Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code :	MCP-2056
Price :	$4500
Companies :	44

Pages :	274
Date :	October 2010
Market Data Tables :	115

Complimentary Copy of Study Findings:

Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.

SPECIALTY ENZYMES (Complete Report)

Pages : 274

$4500

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS.......1

$295

Study Reliability And Reporting Limitations.......1

Disclaimers.......2

Data Interpretation & Reporting Level.......3

Quantitative Techniques & Analytics.......3

Product Definitions And Scope Of Study.......3

Specialty Medical Enzymes.......4

Polymerases.......4

Nucleases.......4

Other Specialty Enzymes.......4

Pharmaceuticals/Diagnostic.......4

Research/Biotechnology.......4

2. GLOBAL MARKET OVERVIEW........5

$395

Current and Future Analysis........5

$100

Recession Derails the Market Momentum........6

Competitive Scenario........6

Table 1: Leading Players in the Global Enzyme Market (2009): Percentage Breakdown of Value Sales for Novozymes, Danisco, Genzyme, Roche, Allergan, DSM and Others (includes corresponding Graph/Chart)........6

$350

3. ENZYMES - A REVIEW........7

Definition........7

Introduction........7

$100

Advantages of Enzymes Compared to Chemical Catalysts........8

A Brief History........8

$100

4. SPECIALTY ENZYMES: AN OVERVIEW........9

Analysis of Product Segments........9

Specialty Medical Enzymes........9

$100

Polymerases........10

Nucleases........10

Other Specialty Enzymes........10

$100

5. ANALYSIS OF THE END-USE MARKETS........11

Pharmaceuticals & Diagnostics........11

Research/Biotechnology........11

Other End Use Markets........11

$100

6. TECHNOLOGY TRENDS........12

Protein Engineering Technology........12

Specialty Enzymes in Industrial Uses........12

$100

Enzyme Technology in Pig Industry........13

$100

7. PRODUCT INTRODUCTIONS/INNOVATIONS........14

Verenium Launches Xylathin........14

Novagen Introduces Novagen® KOD XtremeTM Hot Start DNA Polymerase Kit........14

Verenium Launches New Veretase High-Performance Enzyme........14

$200

8. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST – A PERSPECTIVE BUILDER........16

MARDI Develops Taq DNA Polymerase........16

Stratagene Corporation Commercializes DNA Polymerases........16

Takara Bio Launches PrimeSTAR HS DNA Polymerase........16

$100

9. RECENT INDUSTRY ACTIVITY........17

$295

Thermo Fisher Scientific Acquires Finnzymes........17

Verenium and Add Food Service Enter into an Agreement........17

Verenium and Syngenta End Collaborative Research Program........17

$100

Verenium Collaborates with Alfa Laval for Purifine PLC Enzyme........18

Verenium and Bunge Enter into an Agreement for Enzyme Process Development........18

$100

Inverness Medical Innovations Acquires BBI Holdings Plc........19

Helix Biopharma Enters into a Contract with KBI Biopharma........19

Verenium Enters into Agreement with Bunge Oils........19

$100

10. CORPORATE ACTIVITY IN RECENT PAST – A PERSPECTIVE BUILDER........20

$295

BBI Holdings Acquires Theratase Plc........20

Danisco to Acquire Stake in South African Firm........20

Affymetrix to Buy USB Corporation........20

Diversa Merges with Celunol to Form Verenium Corporation........20

Diversa Collaborates with BASF........20

$100

Codexis Expands Collaboration with Royal Dutch Shell to Develop Super Enzymes........21

Diversa Enters into a Deal with Syngenta to Develop Enzymes........21

Genencor Begins Operation at New China Site and Introduces a New Detergent

Enzyme........21

Verenium Receives $4.6 million For Enzyme Development........21

Biocon Divests its Enzymes Business to Novozymes........21

$100

Solexa Signs Agreement with New England Biolabs........22

Danisco Takes Over Genencor........22

IBEX Technologies Inks Agreement with Cape Cod and Prozyme........22

$100

11. FOCUS ON SELECT GLOBAL PLAYERS........23

$395

Advanced Enzymes Technologies Limited (India)........23

Amano Enzyme, Inc. (Japan)........23

Aureozyme, Inc. (US)........23

$100

Biocon Ltd. (India)........24

Biozyme Laboratories Limited (UK)........24

$100

Danisco A/S (Denmark)........25

Genencor International, Inc. (US)........25

$100

Kinetic Biosystems, Inc. (US)........26

Maxygen, Inc. (US)........26

Codexis Inc. (US)........26

Novozymes A/S (Denmark)........26

$100

Seravac Biotech (Pty) Ltd. (South Africa)........27

Specialty Enzymes & Biotechnologies Co. (US)........27

Verenium Corporation (US)........27

$100

12. GLOBAL MARKET PERSPECTIVE........28

Table 2: World Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........28

$350

Table 3: World Historic Review for Specialty Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........29

$350

Table 4: World 11-Year Perspective for Specialty Enzymes by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........30

$350

Table 5: World Recent Past, Current & Future Analysis for Specialty Medical Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........31

$350

Table 6: World Historic Review for Specialty Medical Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........32

$350

Table 7: World 11-Year Perspective for Specialty Medical Enzymes by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........33

$350

Table 8: World Recent Past, Current & Future Analysis for Polymerases by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........34

$350

Table 9: World Historic Review for Polymerases by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........35

$350

Table 10: World 11-Year Perspective for Polymerases by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........36

$350

Table 11: World Recent Past, Current & Future Analysis for Nucleases by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........37

$350

Table 12: World Historic Review for Nucleases by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........38

$350

Table 13: World 11-Year Perspective for Nucleases by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........39

$350

Table 14: World Recent Past, Current & Future Analysis for Other Specialty Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........40

$350

Table 15: World Historic Review for Other Specialty Enzymes by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........41

$350

Table 16: World 11-Year Perspective for Other Specialty Enzymes by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........42

$350

Table 17: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........43

$350

Table 18: World Historic Review for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........44

$350

Table 19: World 11-Year Perspective for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........45

$350

Table 20: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........46

$350

Table 21: World Historic Review for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........47

$350

Table 22: World 11-Year Perspective for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........48

$350

Table 23: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........49

$350

Table 24: World Historic Review for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........50

$350

Table 25: World 11-Year Perspective for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........51

$350

13. THE UNITED STATES........52

$1950

A. Market Analysis........52

Current and Future Analysis........52

Competitive Scenario........52

Table 26: Leading Players in the US Enzyme Market (2008): Percentage Breakdown of Value Sales for Novozymes, Danisco, Allergan, Genzyme, Genentech, and Others (includes corresponding Graph/Chart)........52

$350

Market Dynamics........53

Specialty Enzymes Market is Projected to Rise........53

Specialty Enzymes Form the Leading Enzymes Segment........53

Pharmaceuticals and Diagnostics Continue to be the Largest Market........53

Specialty Medical Enzymes in a Myriad of Novel Applications........53

Market for Enzymes in Biotechnology........53

$100

B. Market Analytics........54

Table 27: US Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........54

$350

Table 28: US Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........55

$350

Table 29: US 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........56

$350

Table 30: US Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........57

$350

Table 31: US Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........58

Table 32: US 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........58

$350

14. CANADA........59

$1450

Market Analysis........59

Table 33: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015(includes corresponding Graph/Chart)........59

$350

Table 34: Canadian Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........60

$350

Table 35: Canadian 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........61

$350

Table 36: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........62

$350

Table 37: Canadian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........63

Table 38: Canadian 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........63

$350

15. JAPAN........64

$1450

Market Analysis........64

Table 39: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........64

$350

Table 40: Japanese Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........65

$350

Table 41: Japanese 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........66

$350

Table 42: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........67

$350

Table 43: Japanese Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........68

Table 44: Japanese 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........68

$350

16. EUROPE........69

$2950

Market Analysis........69

$100

Table 45: European Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region – France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........70

$350

Table 46: European Historic Review for Specialty Enzymes by Geographic Region – France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........71

$350

Table 47: European 11-Year Perspective for Specialty Enzymes by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........72

$350

Table 48: European Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........73

$350

Table 49: European Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........74

$350

Table 50: European 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........75

$350

Table 51: European Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........76

$350

Table 52: European Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........77

$350

Table 53: European 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........78

$350

16a. FRANCE........79

$1450

Market Analysis........79

Table 54: French Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........79

$350

Table 55: French Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........80

$350

Table 56: French 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........81

$350

Table 57: French Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........82

$350

Table 58: French Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........83

Table 59: French 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........83

$350

16b. GERMANY........84

$1450

Market Analysis........84

Table 60: German Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........84

$350

Table 61: German Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........85

$350

Table 62: German 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........86

$350

Table 63: German Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........87

$350

Table 64: German Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........88

Table 65: German 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........88

$350

16c. ITALY........89

$1450

Market Analysis........89

Table 66: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........89

$350

Table 67: Italian Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........90

$350

Table 68: Italian 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........91

$350

Table 69: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........92

$350

Table 70: Italian Historic Review for Specialty Enzymes by End-Use Segment – Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........93

Table 71: Italian 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........93

$350

16d. THE UNITED KINGDOM........94

$1450

Market Analysis........94

Table 72: UK Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........94

$350

Table 73: UK Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........95

$350

Table 74: UK 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........96

$350

Table 75: UK Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........97

$350

Table 76: UK Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........98

Table 77: UK 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for2005, 2010 & 2015 (includes corresponding Graph/Chart)........98

$350

16e. SPAIN........99

$1450

Market Analysis........99

Table 78: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........99

$350

Table 79: Spanish Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........100

$350

Table 80: Spanish 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015(includes corresponding Graph/Chart)........101

$350

Table 81: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015(includes corresponding Graph/Chart)........102

$350

Table 82: Spanish Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........103

Table 83: Spanish 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........103

$350

16f. RUSSIA........104

$1450

Market Analysis........104

Table 84: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........104

$350

Table 85: Russian Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........105

$350

Table 86: Russian 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........106

$350

Table 87: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........107

$350

Table 88: Russian Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........108

Table 89: Russian 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........108

$350

16g. REST OF EUROPE........109

$1950

Market Analysis........109

Table 90: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........109

$350

Table 91: Rest of Europe Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........110

$350

Table 92: Rest of Europe 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........111

$350

Table 93: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........112

$350

Table 94: Rest of Europe Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........113

$350

Table 95: Rest of Europe 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........114

$350

17. ASIA-PACIFIC........115

$1995

A. Market Analysis........115

Current and Future Analysis........115

Enzyme Market in China........115

Enzyme Demand by End-Use........115

$100

Table 96: Chinese Enzyme Market (2009): Percentage Breakdown of Dollar Demand by End-Use Market – Industrial (Food & Beverage, Cleaning Products, Animal Feed, Ethanol Production, and Other Industrial) and Specialty (includes corresponding Graph/Chart)........116

Enzyme Demand by Enzyme Type........116

Table 97: Chinese Enzyme Market (2009): Percentage Breakdown of Dollar Demand by Enzyme Type – Carbohydrases (Amylases and Other Carbohydrases), Proteases, Lipases, Polymerases & Nucleases, and Other Enzymes (includes corresponding Graph/Chart)........116

$350

B. Market Analytics........117

Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........117

$350

Table 99: Asia-Pacific Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........118

$350

Table 100: Asia-Pacific 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........119

$350

Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........120

$350

Table 102: Asia-Pacific Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........121

$350

Table 103: Asia-Pacific 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........122

$350

18. THE MIDDLE EAST........123

$1950

Market Analysis........123

Table 104: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........123

$350

Table 105: Middle East Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........124

$350

Table 106: Middle East 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........125

$350

Table 107: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........126

$350

Table 108: Middle East Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........127

$350

Table 109: Middle East 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........128

$350

19. LATIN AMERICA........129

$1950

Market Analysis........129

Table 110: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........129

$350

Table 111: Latin American Historic Review for Specialty Enzymes by Product Segment – Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........130

$350

Table 112: Latin American 11-Year Perspective for Specialty Enzymes by Product Segment – Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........131

$350

Table 113: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........132

$350

Table 114: Latin American Historic Review for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........133

$350

Table 115: Latin American 11-Year Perspective for Specialty Enzymes by End-Use Segment – Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart)........134

$350

COMPETITION

125

$995

Total Companies Profiled: 44 (including Divisions/Subsidiaries - 46)
Region/Country                 Players

The United States                 25   
Canada                             3
Japan                              2
Europe                            11
     Germany                       1
     The United Kingdom            2
     Rest of Europe                8
Asia-Pacific (Excluding Japan)     4
Africa                             1

Click here to request a full table of contents and more details on this project.

SPECIALTY ENZYMES - A GLOBAL STRATEGIC BUSINESS REPORT

Research Abstract

Complimentary Copy of Study Findings:

TABLE OF CONTENTS

SPECIALTY ENZYMES - A GLOBAL STRATEGIC BUSINESS REPORT stLight.options({ publisher:'12345' });

Research Abstract

Complimentary Copy of Study Findings:

TABLE OF CONTENTS

SPECIALTY ENZYMES - A GLOBAL STRATEGIC BUSINESS REPORT